HER2-targeted Antibodies
- Name
- HER2-targeted Antibodies
- Accession Number
- DBCAT005683
- Description
Not Available
- Drugs
Drug Drug Description Trastuzumab emtansine An antineoplastic agent and antibody-drug conjugate used to treat HER2-overexpressing breast cancer. - Drugs & Drug Targets